Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients

Interferons (IFNs) are widely used in treating coronavirus disease 2019 (COVID-19) patients. However, a recent report of ACE2, the host factor mediating SARS-Cov-2 infection, identifying it as interferon-stimulated raised considerable safety concern. To examine the association between the use and ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nan, Zhan, Yan, Zhu, Linyu, Hou, Zhibing, Liu, Feng, Song, Pinhong, Qiu, Feng, Wang, Xiaolin, Zou, Xiafei, Wan, Deyun, Qian, Xiaosong, Wang, Shanshan, Guo, Yabi, Yu, Hao, Cui, Miao, Tong, Gangling, Xu, Yunsheng, Zheng, Zhihua, Lu, Yingying, Hong, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368656/
https://www.ncbi.nlm.nih.gov/pubmed/32707096
http://dx.doi.org/10.1016/j.chom.2020.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368656/
https://www.ncbi.nlm.nih.gov/pubmed/32707096
http://dx.doi.org/10.1016/j.chom.2020.07.005

Ejemplares similares